9 hours ago | Blogs
QbD is financially important for the pharmaceutical industry and highly beneficial for the consumers; as it will ensure quality all the time, potentially alleviate shortages and lower costs.
|
12 hours ago | Video
A government panel says men shouldn't have routine PSA screening tests for prostate cancer. The American Cancer Society's Dr. Otis Brawley says the tests may kill more men than they save, but former Notre Dame basketball coach and prostate cancer survivor Digger Phelps says a PSA test helped save his life.
|
12 hours ago | News
Veloxis Pharmaceuticals A/S today announced that it contemplates restructuring the company's operations in order to fully focus its resources on the completion of the development and subsequent commercialization of LCP-TacroT, Veloxis' product candidate for the prevention of organ rejection.
|
13 hours ago | News
CHARLOTTE, N.C. (AP) — Chelsea Therapeutics International Ltd. said Tuesday it may have to make changes to a clinical trial of its drug candidate Northera, potentially delaying its approval.
|
13 hours ago | News
Pfizer Inc. named Olivier Brandicourt as President and General Manager of the Emerging Markets and Established Products Business Units, effective June 1, 2012.
|
13 hours ago | News
Pharmaceutical Product Development, LLC (PPD) today announced that its board of directors has named David Simmons chairman and CEO.
|
May 22 | News
InterMune, Inc. today announced that it has reached a definitive agreement with Vidara Therapeutics International Limited to sell its rights to Actimmune® (interferon gamma-1b) in a cash transaction valued at $55 million plus a two-year royalty stream.
|
May 22 | News
WASHINGTON (AP) — The Food and Drug Administration said Monday that a blood thinner from Johnson & Johnson appears to reduce life-threatening blood clots in high-risk patients, although it also increases the risk of internal bleeding.
|
May 22 | News
HANOI, Vietnam (AP) — More than a third of the malaria-fighting drugs tested over the past decade in Southeast Asia and sub-Saharan Africa were either fake or bad quality, seriously undermining efforts to fight the disease, a study said Tuesday.
|
May 22 | News
WASHINGTON (AP) — Healthy men shouldn't get routine prostate cancer screenings, says updated advice from a government panel that found the PSA blood tests do more harm than good.
|